Purchase Order 15B50523P00000030
Award Date 2/1/23
Potential Completion Date 2/2/24
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Los Angeles, CA 90032, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- On February 8, 2024, the Department of Veterans Affairs, Veterans Integrated Service Network 20, awarded a delivery order valued at $96,618.03 to Grifols USA LLC for PROLASTIN-C, an alpha1-proteinase inhibitor pharmaceutical product used to treat alpha1-antitrypsin deficiency. This firm fixed-price delivery order, which will be completed by February 8, 2025, was issued without a set-aside designation and represents performance under the Pharmaceuticals and Drugs Federal Supply Schedule...
- The U.S. Department of Veterans Affairs (VA) awarded a $100,800.00 Firm Fixed Price Delivery Order contract to Grifols USA LLC for the provision of PROLASTIN-C, an alpha1-proteinase inhibitor drug used to treat alpha1-antitrypsin deficiency. This contract is part of Grifols' $1.38 billion Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs with the VA. The contract has a period of performance through February 8, 2026 and was awarded without a set-aside designation,...
- This federal contract award is to Grifols USA LLC, a global healthcare company, by the Department of Veterans Affairs Veterans Health Administration. The contract is for the delivery of PROLASTIN, a pharmaceutical product, with a potential value of $59,192.70. The contract is a delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is priced on a firm fixed price basis. The contract does not have a set-aside designation. Grifols USA LLC is the prime contractor...
- This delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awards Grifols USA LLC $502,920.80 to supply Prolastin-C Liquid, Human 1000mg/vial under the firm fixed price contract. The order is placed against Grifols' Pharmaceuticals and Drugs Schedule contract with the General Services Administration and requires delivery by September 30, 2023. No set-aside provision was applied to this order. Grifols will provide the...
- The Department of Veterans Affairs Veterans Health Administration (VA VHA) awarded a firm fixed price delivery order contract for PROLASTIN C, a pharmaceutical product, to Grifols Therapeutics LLC, a for-profit limited liability company and manufacturer. The contract was awarded on October 1, 2021 with a potential value of $454,461.44 and a completion date of September 30, 2022. The contract was issued under the Pharmaceuticals and Drugs GSA Schedule, which is a government-wide acquisition...
- This is a federal contract award for the pharmaceutical product Prolastin, awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is a delivery order under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule, with a firm fixed price and a ceiling value of $162,548.16. This award does not utilize any small business set-asides. Grifols Therapeutics LLC...
- This federal contract award is for a Blanket Purchase Agreement (BPA) call from the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 7 to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is for the delivery of Prolastin, a pharmaceutical product, with a potential value of $125,209.92. The contract does not utilize any small business set-asides and is a Firm Fixed...
- This federal contract award is for the drug Prolastin (Prolastin-C, alpha1-proteinase inhibitor) 1000mg/vial injection, with a National Drug Code (NDC) of 13533-0703-10. The contract, worth $193,110.72, was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 20 to Grifols Therapeutics LLC, a for-profit pharmaceutical manufacturer. The contract is a blanket purchase agreement (BPA) call order, with a firm fixed price...
- This federal contract award, valued at $161,280.00, was issued by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs (VA) to the prime contractor Grifols Therapeutics LLC. The contract is a delivery order placed against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) held by Grifols. The award is for the provision of pharmaceutical medication, with no set-aside designation. Grifols Therapeutics LLC is a for-profit manufacturer and...
- This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract, valued at $197,165.04, is for the provision of pharmaceutical products to the VA under the Pharmaceuticals and Drugs GSA Schedule 61-IB. The contract has a firm fixed price pricing structure and was not set aside for small businesses. Grifols has previously provided similar...